M7 News
Top stories
Prediction markets for M7
Will the M72/AS01E tuberculosis vaccine candidate have an efficacy of 50% or higher in the phase 3 trial?
Aug 24, 4:14 PMDec 31, 11:59 PM
58.76%chance
424
OptionVotes
97
83
Latest stories
Latest stories
OptionVotes
97
83